These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 15017595

  • 1. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry.
    Sarbia M, Donner A, Franke C, Gabbert HE.
    Hum Pathol; 2004 Mar; 35(3):371-6. PubMed ID: 15017595
    [Abstract] [Full Text] [Related]

  • 2. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D, Spiethoff A, Rosenbaum A, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer MH, Riemann JF.
    Pathol Res Pract; 2005 Mar; 200(11-12):801-5. PubMed ID: 15792123
    [Abstract] [Full Text] [Related]

  • 3. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
    Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L.
    World J Gastroenterol; 2005 Oct 28; 11(40):6360-5. PubMed ID: 16419166
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
    Gulmann C, Shaqaqi OA, Grace A, Leader M, Patchett S, Butler D, Kay E.
    Appl Immunohistochem Mol Morphol; 2004 Jun 28; 12(2):142-7. PubMed ID: 15354740
    [Abstract] [Full Text] [Related]

  • 5. Comparison of intestinal metaplasia in gastric cardia and Barrett's esophagus.
    Miao Q, Peng YS, Cai GH, Chen XY.
    J Dig Dis; 2011 Aug 28; 12(4):272-8. PubMed ID: 21791021
    [Abstract] [Full Text] [Related]

  • 6. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, DeMeester TR.
    Am J Gastroenterol; 2002 Oct 28; 97(10):2514-23. PubMed ID: 12385432
    [Abstract] [Full Text] [Related]

  • 7. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA, Streutker CJ, Riddell RH.
    Mod Pathol; 2002 Jun 28; 15(6):611-6. PubMed ID: 12065774
    [Abstract] [Full Text] [Related]

  • 8. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
    El-Zimaity HM, Graham DY.
    Am J Gastroenterol; 2001 May 28; 96(5):1378-82. PubMed ID: 11374671
    [Abstract] [Full Text] [Related]

  • 9. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.
    White NM, Gabril M, Ejeckam G, Mathews M, Fardy J, Kamel F, Doré J, Yousef GM.
    Can J Gastroenterol; 2008 Apr 28; 22(4):369-75. PubMed ID: 18414711
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
    Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL.
    Hum Pathol; 1999 Mar 28; 30(3):288-94. PubMed ID: 10088547
    [Abstract] [Full Text] [Related]

  • 11. Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.
    Chang Y, Liu B, Liu GS, Wang T, Gong J.
    World J Gastroenterol; 2010 Dec 28; 16(48):6151-4. PubMed ID: 21182233
    [Abstract] [Full Text] [Related]

  • 12. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
    Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL.
    Gastroenterology; 2000 Sep 28; 119(3):683-90. PubMed ID: 10982762
    [Abstract] [Full Text] [Related]

  • 13. Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus.
    Glickman JN, Ormsby AH, Gramlich TL, Goldblum JR, Odze RD.
    Hum Pathol; 2005 Jan 28; 36(1):58-65. PubMed ID: 15712183
    [Abstract] [Full Text] [Related]

  • 14. The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia.
    Oh DS, DeMeester SR, Tanaka K, Marjoram P, Kuramochi H, Vallbohmer D, Danenberg K, Chandrasoma PT, DeMeester TR, Hagen JA.
    Dis Esophagus; 2011 Sep 28; 24(7):516-22. PubMed ID: 21309924
    [Abstract] [Full Text] [Related]

  • 15. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P.
    Histol Histopathol; 2002 Apr 28; 17(2):445-54. PubMed ID: 11962749
    [Abstract] [Full Text] [Related]

  • 16. Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barrett's oesophagus in Korea?
    Yim HJ, Lee SW, Choung RS, Kim YS, Kim JY, Lee HS, Song CW, Choi JH, Bak YT, Ryu HS, Hyun JH, Kim DS, Kim CH.
    Eur J Gastroenterol Hepatol; 2005 Jun 28; 17(6):611-6. PubMed ID: 15879722
    [Abstract] [Full Text] [Related]

  • 17. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
    Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Fléjou JF, Groupe d'Etude l'Oesophage de Barrett.
    Gut; 2001 Dec 28; 49(6):761-6. PubMed ID: 11709508
    [Abstract] [Full Text] [Related]

  • 18. Cytokeratin and CDX-2 expression in Barrett's esophagus.
    van Baal JW, Bozikas A, Pronk R, Ten Kate FJ, Milano F, Rygiel AM, Rosmolen WD, Peppelenbosch MP, Bergman JJ, Krishnadath KK.
    Scand J Gastroenterol; 2008 Dec 28; 43(2):132-40. PubMed ID: 18224560
    [Abstract] [Full Text] [Related]

  • 19. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
    Wang R, Xie J, Shen Y, Ren T.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec 28; 32(12):1820-3. PubMed ID: 23268419
    [Abstract] [Full Text] [Related]

  • 20. Detection of cardia intestinal metaplasia: do the biopsy number and location matter?
    Sharma P, McElhinney C, Topalovski M, Mayo MS, McGregor DH, Weston A.
    Am J Gastroenterol; 2004 Dec 28; 99(12):2424-8. PubMed ID: 15571591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.